Dallas, TX, October 05, 2017 --(PR.com
)-- TupeloLife will present at the American Heart Association’s Health Tech & Innovation Forum, October 4-5 in Boston. The Health Tech & Innovation Forum will gather top healthcare providers and researchers, health technology experts, industry thought leaders and entrepreneurs from the world’s most renowned companies and institutions to consider how technology can measurably improve health outcomes.
“We are thrilled to attend this event again and continue to participate in the dialogue around technology, healthcare, and innovation.” -Dr. Eric Hazzard, Chief Scientific Officer
In 2016, as founding members, TupeloLife joined the Health Tech Collaborative, AHA’s Center for Health Technology and Innovation (CHTI) consortium of strategic collaborations that will formally link entrepreneurs, providers, researchers, and patients. American Heart Association created the CHTI to give the patient a more substantive and influential voice in the evolution of digital health technology, and to allow health tech companies more meaningful opportunities to engage providers and patients on a personal level.
TupeloLife is a connected health company focused on creating technology for the areas of your life that matter: Health, Safety, Security, and Environment. TupeloLife offers the Precision Care Platform, a complete ecosystem comprised of hardware, software, and services aligned to address the needs of connected medical homes, beyond medication management (hospital networks, and healthcare providers), precision medicine initiatives and pharmaceutical research, and bundled payments for care improvement initiatives.
About TupeloLife: A long-standing partner of the AHA, TupeloLife is a connected healthcare company, connecting the areas of your life that matter: Health, Safety, Security, and Environment. As a global healthcare solutions company, TupeloLife has offices in Dallas,Texas; Paderborn, Germany; Doha, Qatar; Dubai, UAE and Bangalore, India.